Answer questions and earn CME/CNE Over the past few decades, a body of research has
emerged confirming what many adult patients with noncentral nervous system cancer have …

Cognitive changes associated with cancer and cancer treatments have become an
increasing concern. Using breast cancer as the prototype, we reviewed the research from …

This brief review explores the areas of cognitive impairment that have been observed in
cancer patients and survivors, the cognitive assessment tools used, and the management of …

The anthracycline doxorubicin (DOX) is widely used in chemotherapy due to its efficacy in
fighting a wide range of cancers such as carcinomas, sarcomas and hematological cancers …

Purpose Adjuvant chemotherapy for breast cancer can have adverse effects on cognition
shortly after administration. Whether chemotherapy has any long-term effects on cognition is …

The integration of psychosocial care into the routine care of all patients with cancer is
increasingly being recognized as the new standard of care. These NCCN Clinical Practice …

Many cancer patients treated with chemotherapy develop chemotherapy-induced cognitive
impairment (CICI), often referred to as chemo-brain, which manifest during or post-treatment …

The mechanism (s) for chemotherapy-induced cognitive changes are largely unknown;
however, several candidate mechanisms have been identified. We suggest that shared …

Purpose To examine the impact of age and cognitive reserve on cognitive functioning in
patients with breast cancer who are receiving adjuvant treatments. Patients and Methods …

BACKGROUND: Growing evidence supports cognitive dysfunction associated with standard
dose chemotherapy in breast cancer survivors. We determined the incidence, nature, and …